MDSA at EHA 2024

We are thrilled to have the opportunity to attend the European Hematology Association (EHA) Congress in Madrid from June 13-16. The agenda will be packed with captivating activities aimed at advancing awareness and understanding of hematological conditions, like MDS. Additionally, attendees will delve into the latest research unveiled at EHA.

These are some of the sessions dedicated to analyse the present and future of MDS.

• Navigating the Evolving Treatment Landscape in Lower-risk MDS. On Thursday 13th June at 10.15.
• MDS Symposia. Thursday 13th at 19.15
• Working group session on 15th June: Myelodysplastic syndromes (MDS): Immune dysregulation in bone marrow failure disorders: Time for immune monitoring?

The scientific agenda will spotlight cutting-edge hematology and an array of subjects, encompassing hemostasis and thrombosis, hematologic malignancies, transfusion medicine, and stem cell transplantation.

Beyond the scientific sessions, the EHA2024 Hybrid Congress presents a chance for participants to forge connections, engage with peers, and interact with experts and industry associates.

Translate »